Correlation Between Royal Bank and Helix BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Royal Bank and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Bank and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Royal Bank of and Helix BioPharma Corp, you can compare the effects of market volatilities on Royal Bank and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Bank with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Bank and Helix BioPharma.

Diversification Opportunities for Royal Bank and Helix BioPharma

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Royal and Helix is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Royal Bank of and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and Royal Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Bank of are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of Royal Bank i.e., Royal Bank and Helix BioPharma go up and down completely randomly.

Pair Corralation between Royal Bank and Helix BioPharma

Assuming the 90 days trading horizon Royal Bank is expected to generate 14.08 times less return on investment than Helix BioPharma. But when comparing it to its historical volatility, Royal Bank of is 15.17 times less risky than Helix BioPharma. It trades about 0.3 of its potential returns per unit of risk. Helix BioPharma Corp is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  70.00  in Helix BioPharma Corp on September 19, 2024 and sell it today you would earn a total of  25.00  from holding Helix BioPharma Corp or generate 35.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Royal Bank of  vs.  Helix BioPharma Corp

 Performance 
       Timeline  
Royal Bank 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Royal Bank of are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Royal Bank is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Helix BioPharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Helix BioPharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Royal Bank and Helix BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Royal Bank and Helix BioPharma

The main advantage of trading using opposite Royal Bank and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Bank position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.
The idea behind Royal Bank of and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device